Industry Focus

After releasing its first quarter financials, J&J's stock fell over 3%. Is it a buy? In this episode, we dig into the quarter's highlights and low-lights to find out.

Direct download: 20170419_IF_Healthcare.mp3
Category:general -- posted at: 3:30pm EST

1